Gadobutrol is a second-generation, macrocyclic, non-ionic gadolinium-based contrast agent used in magnetic resonance imaging (MRI). It is formulated at twice the gadolinium ion concentration compared to other agents, allowing for a smaller injection volume.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 770691-21-9
Gadovist
pharmaceutical raw material
Calcium 2,2'-[7-(carboxymethyl)-10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4-diyl]diacetate
pharmaceutical intermediate
2,2'-(4,10-bis(1,3,4-Trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid
pharmaceutical intermediate
2,2'-(4,10-Bis(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid tetrahydrochloride
pharmaceutical raw material
Gadopentetate dimeglumine
pharmaceutical raw material
Gadoterate meglumine
pharmaceutical raw material
Gadopiclenol
pharmaceutical raw material
Gadoteridol
pharmaceutical raw material
2-[4,10-bis(carboxylatomethyl)-7-[(2R,3S)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
ZPDFIIGFYAHNSK-CTHHTMFSSA-K
C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])[C@H](CO)[C@@H](CO)O)CC(=O)[O-].[Gd+3]